Unsafe
Not Aligned
Patient Risk:
High
Summary
The provided label excerpts appear to be for DULERA (mometasone furoate/formoterol inhalation), not mometasone furoate 0.1% cream topical therapy. Nearly all cream-specific indications, dosing, side effects, potency, and generic-equivalence claims are unsupported by the supplied label sections, creating high risk of label-mismatch.
Category Scores
Accurate Statements
Mometasone furoate is a corticosteroid.
Supported by provided label excerpt 11 DESCRIPTION (describes mometasone furoate as a corticosteroid).
Unsupported Statements
Mometasone furoate works by reducing inflammation, itching, and redness associated with certain skin conditions.
No supported indication/mechanism statements for mometasone furoate 0.1% cream topical use in the provided label excerpts.
Mometasone furoate achieves this by inhibiting the release of substances in the body that cause inflammation.
No provided label excerpt supports this mechanism for topical cream.
Mometasone furoate 0.1% cream is prescribed to treat inflammatory skin conditions, including eczema.
No provided label excerpt for mometasone furoate 0.1% cream topical indications.
Mometasone furoate 0.1% cream is prescribed to treat inflammatory skin conditions, including psoriasis.
No provided label excerpt for mometasone furoate 0.1% cream topical indications.
Mometasone furoate 0.1% cream is prescribed to treat inflammatory skin conditions, including dermatitis.
No provided label excerpt for mometasone furoate 0.1% cream topical indications.
Mometasone furoate 0.1% cream is prescribed to treat inflammatory skin conditions, including other allergic skin reactions.
No provided label excerpt for mometasone furoate 0.1% cream topical indications.
Mometasone furoate 0.1% cream is a mid-potency corticosteroid.
No potency classification for mometasone furoate 0.1% cream in provided label excerpts.
Mometasone furoate 0.1% cream is suitable for use on the face, body, and scalp for moderate to severe conditions.
No provided label excerpt supports use-site/suitability or severity limitations for this topical cream.
Common side effects ... may include burning at the application site.
No adverse reaction section for mometasone furoate 0.1% cream topical use was provided.
Common side effects ... may include itching at the application site.
No adverse reaction section for mometasone furoate 0.1% cream topical use was provided.
Common side effects ... may include irritation at the application site.
No adverse reaction section for mometasone furoate 0.1% cream topical use was provided.
Common side effects ... may include redness at the application site.
No adverse reaction section for mometasone furoate 0.1% cream topical use was provided.
Common side effects ... may include dryness at the application site.
No adverse reaction section for mometasone furoate 0.1% cream topical use was provided.
More serious side effects ... can occur with prolonged or extensive use.
No topical prolonged-use safety warnings/precautions in provided label excerpts.
Serious side effects ... may include skin thinning.
No topical safety warning/precaution for skin thinning in provided label excerpts.
Serious side effects ... may include stretch marks.
No topical safety warning/precaution for stretch marks in provided label excerpts.
Serious side effects ... may include acne.
No topical safety warning/precaution for acne in provided label excerpts.
Serious side effects ... may include changes in skin color.
No topical safety warning/precaution for dyspigmentation in provided label excerpts.
The typical dosage ... involves applying a thin layer ... once or twice daily.
No topical dosing instructions for mometasone furoate 0.1% cream were provided.
Dosage ... may be applied once or twice daily or as directed by a physician.
No topical dosing instructions were provided.
Many individuals notice improvement ... within the first week ...
No efficacy/treatment-response timeline in provided label excerpts for topical cream.
Full therapeutic effect ... may take longer to be achieved than the first week.
No efficacy timeline support in provided label excerpts for topical cream.
Continued use as prescribed is often necessary to achieve full therapeutic effect.
No label support in provided excerpts.
Generic mometasone furoate 0.1% cream contains the same active ingredient, mometasone furoate.
No generic-equivalence labeling content in provided excerpts.
Generic mometasone furoate 0.1% cream contains the same strength and dosage form as the brand-name product.
No generic/bioequivalence labeling content in provided excerpts.
Generic medications are approved by regulatory agencies.
Not addressed in provided label excerpts.
Generic medications are considered bioequivalent to their brand-name counterparts.
Not addressed in provided label excerpts.
The primary difference between generic and brand-name ... usually lies in inactive ingredients and cost.
Not addressed in provided label excerpts.
Generic products are more affordable than brand-name products.
Not addressed in provided label excerpts.
Contradictions
Important Omissions
Contraindications for mometasone furoate 0.1% cream were not provided/assessed.
Importance:
High
Boxed warning(s) for mometasone furoate 0.1% cream were not provided/assessed.
Importance:
High
Topical corticosteroid warnings/precautions (including local adverse reactions and systemic effects with prolonged use) for mometasone furoate 0.1% cream were not provided/assessed.
Importance:
High
Topical dosing and administration directions specific to mometasone furoate 0.1% cream (frequency, duration limits, and application instructions) were not provided/assessed.
Importance:
High
Adverse reactions section specific to mometasone furoate 0.1% cream (including incidence or listed adverse events) was not provided/assessed.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Cream-specific claims (indications, dosing, onset, potency, and adverse reactions) are largely unsupported by the provided label excerpts, which appear to be for a different product/route (DULERA inhalation). This increases risk of misinformation being presented as label-adherent.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Provided label excerpts do not contain topical mometasone furoate 0.1% cream indications/dosing/safety information; nearly all cream claims are unsupported.
Suggested Improvement
Re-run the audit using the correct FDA-approved prescribing information for mometasone furoate 0.1% cream (topical product). Ensure each claim maps to a specific label section (Indications and Usage, Dosage and Administration, Contraindications, Warnings and Precautions, Adverse Reactions, and Use in Specific Populations) with exact citations.